Review of the efficacy and tolerability of the diclofenac epolamine topical patch 1.3% in patients with acute pain due to soft tissue injuries

Keyphrases

• Soft Tissue Injuries 100%
• Acute Pain 100%
• Tolerability 100%
• Diclofenac Epolamine 100%
• Topical Patch 100%
• Placebo 30%
• Day 14 30%
• Adverse Events 20%
• Exclusion Criteria 20%
• Controlled Clinical Study 20%
• MEDLINE 10%
• Pain Relief 10%
• Placebo-controlled 10%
• As(III) 10%
• Dermatitis 10%
• U.S. Food 10%
• Spontaneous Pain 10%
• Diclofenac 10%
• Medical Conditions 10%
• Median Time 10%
• Gastrointestinal Diseases 10%
• Visual Analog Scale 10%
• Contusion 10%
• Nausea 10%
• Pain Score 10%
• Periarticular 10%
• Rash 10%
• Embase 10%
• Pruritus 10%
• Efficacy Study 10%
• Post-marketing Surveillance 10%
• Application Site Reactions 10%
• Pain Resolution 10%
• Postmarketing 10%
• Cutaneous Application 10%
• Countries Worldwide 10%
• Diclofenac Diethylamine 10%
• Sprain 10%
• Topical Gel 10%
• Active Comparator 10%
• Derwent 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Pain 100%
• Tolerability 100%
• Soft Tissue Injury 100%
• Diclofenac Epolamine 100%
• Clinical Study 50%
• Placebo 40%
• Adverse Event 20%
• Diclofenac 20%
• Prevalence 10%
• Dermatitis 10%
• Nausea 10%
• Rash 10%
• Pruritus 10%
• Gastrointestinal Symptom 10%
• Postmarketing Surveillance 10%
• Application Site Reaction 10%
• Efficacy Study 10%
• Contusion 10%
• Topical Gels 10%